Your browser doesn't support javascript.
loading
Prevention of bleomycin-induced lung fibrosis via inhibition of the MRTF/SRF transcription pathway.
Pawelec, Kendell M; Varnum, Megan; Harkema, Jack R; Auerbach, Bruce; Larsen, Scott D; Neubig, Richard R.
Affiliation
  • Pawelec KM; FibrosIX, East Lansing, Michigan, USA.
  • Varnum M; FibrosIX, East Lansing, Michigan, USA.
  • Harkema JR; BBC Entrepreneurial Training and Consulting, Chelsea, Michigan, USA.
  • Auerbach B; Department of Pathology and Diagnostic Investigation, Michigan State University, East Lansing, Michigan, USA.
  • Larsen SD; Department of Pharmacology & Toxicology, Michigan State University, East Lansing, Michigan, USA.
  • Neubig RR; Office of Technology Transfer, University of Michigan, Ann Arbor, Michigan, USA.
Pharmacol Res Perspect ; 10(6): e01028, 2022 12.
Article in En | MEDLINE | ID: mdl-36426895
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pulmonary Fibrosis / Bleomycin Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Pharmacol Res Perspect Year: 2022 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pulmonary Fibrosis / Bleomycin Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Pharmacol Res Perspect Year: 2022 Type: Article Affiliation country: United States